Literature DB >> 21482004

[Relative validity of the 10-year cardiovascular risk estimate in a population cohort of the REGICOR study].

Jaume Marrugat1, Joan Vila, José Miguel Baena-Díez, María Grau, Joan Sala, Rafel Ramos, Isaac Subirana, Montserrat Fitó, Roberto Elosua.   

Abstract

INTRODUCTION AND
OBJECTIVES: Cardiovascular risk screening requires accurate risk functions. The relative validity of the Framingham-based REGICOR adapted function is analyzed and the population distribution of cardiovascular 10-year cardiovascular events is described by risk group.
METHODS: A population cohort of 3856 participants recruited between 1995 and 2000, aged 35 to 74 years from Girona without symptoms of cardiovascular diseases, was followed between 2006 and 2009. Standardized laboratory and blood pressure measurements, questionnaires, and case definitions were used. The follow-up combined cross-linkage of our databases with our regional mortality registry, reexamination, and telephone contact with participants. Coronary disease endpoints alone were considered.
RESULTS: A total of 27 487 person-years were obtained (mean follow-up 7.1 years), and the follow-up was achieved in 97% of participants (120 coronary disease events). Validity was good: the regression coefficients estimated with the cohort data did not differ from those obtained in the original Framingham function. Function calibration was good: the observed incidence of cardiovascular events in the decile groups of risk did not differ from the function prediction (P=.127 in women, and P=.054 in men). The C statistic (discrimination) was 0.82 (95% confidence interval, 0.76-0.88) in women, and 0.78 (95% confidence interval, 0.73-0.83) in men. More than 50% of cardiovascular events occurred in participants whose 10-year risk was 5% to 14.9%.
CONCLUSIONS: The studied function accurately predicts coronary disease events at 10 years. Risk stratification could be simplified in 4 groups: low (<5%), moderate (5%-9.9%), high (10%-14.9%) and very high (≥15%).
Copyright © 2010 Sociedad Española de Cardiología. Published by Elsevier Espana. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21482004     DOI: 10.1016/j.recesp.2010.12.011

Source DB:  PubMed          Journal:  Rev Esp Cardiol        ISSN: 0300-8932            Impact factor:   4.753


  35 in total

1.  Higher prevalence of cerebral white matter hyperintensities in homozygous APOE-ɛ4 allele carriers aged 45-75: Results from the ALFA study.

Authors:  Santiago Rojas; Anna Brugulat-Serrat; Nuria Bargalló; Carolina Minguillón; Alan Tucholka; Carles Falcon; Andreia Carvalho; Sebastian Morán; Manel Esteller; Nina Gramunt; Karine Fauria; Jordi Camí; José L Molinuevo; Juan D Gispert
Journal:  J Cereb Blood Flow Metab       Date:  2017-05-11       Impact factor: 6.200

2.  Assessment of the value of a genetic risk score in improving the estimation of coronary risk.

Authors:  Carla Lluis-Ganella; Isaac Subirana; Gavin Lucas; Marta Tomás; Daniel Muñoz; Mariano Sentí; Eduardo Salas; Joan Sala; Rafel Ramos; Jose M Ordovas; Jaume Marrugat; Roberto Elosua
Journal:  Atherosclerosis       Date:  2012-03-30       Impact factor: 5.162

3.  Effectiveness and cost-effectiveness of an intervention to improve Initial Medication Adherence to treatments for cardiovascular diseases and diabetes in primary care: study protocol for a pragmatic cluster randomised controlled trial and economic model (the IMA-cRCT study).

Authors:  Alba Sánchez-Viñas; Carmen Corral-Partearroyo; Montserrat Gil-Girbau; M Teresa Peñarrubia-María; Carmen Gallardo-González; María-Del-Carmen Olmos-Palenzuela; Ignacio Aznar-Lou; Antoni Serrano-Blanco; Maria Rubio-Valera
Journal:  BMC Prim Care       Date:  2022-07-05

4.  Cholesterol and Hypertension Treatment Improve Coronary Risk Prediction but Not Time-Dependent Covariates or Competing Risks.

Authors:  Isaac Subirana; Anna Camps-Vilaró; Roberto Elosua; Jaume Marrugat; Helena Tizón-Marcos; Ivan Palomo; Irene R Dégano
Journal:  Clin Epidemiol       Date:  2022-10-11       Impact factor: 5.814

5.  Effectiveness of Motivational Interviewing in improving lipid level in patients with dyslipidemia assisted by general practitioners: Dislip-EM study protocol.

Authors:  Luis A Pérula; Josep M Bosch; Julia Bóveda; Manuel Campiñez; Nieves Barragán; Juan C Arboniés; Jose A Prados; Enrique Martín; Remedios Martín; Josep Massons; Margarita Criado; Roger Ruiz; José A Fernández; Francisco Buitrago; Inmaculada Olaya; Modesto Pérez; Joaquin Ruiz
Journal:  BMC Fam Pract       Date:  2011-11-05       Impact factor: 2.497

6.  Economic evaluation of Cardio inCode®, a clinical-genetic function for coronary heart disease risk assessment.

Authors:  A Ramírez de Arellano; A Coca; M de la Figuera; C Rubio-Terrés; D Rubio-Rodríguez; A Gracia; A Boldeanu; J Puig-Gilberte; E Salas
Journal:  Appl Health Econ Health Policy       Date:  2013-10       Impact factor: 2.561

7.  Effectiveness of an intervention designed to optimize statins use: a primary prevention randomized clinical trial.

Authors:  Mireia Fàbregas; Irene Berges; Francesc Fina; Eduardo Hermosilla; Ermengol Coma; Leonardo Méndez; Manuel Medina; Sebastià Calero; Elena Serrano; Rosa Morros; Mònica Monteagudo; Bonaventura Bolíbar
Journal:  BMC Fam Pract       Date:  2014-07-15       Impact factor: 2.497

8.  Relationship between Retinal Microvasculature, Cardiovascular Risk and Silent Brain Infarction in Hypertensive Patients.

Authors:  Rosa Forés; Josep M Manresa; Victor M López-Lifante; Antonio Heras; Pilar Delgado; Xose Vázquez; Susana Ruiz; Maria Teresa Alzamora; Pere Toran
Journal:  Diagnostics (Basel)       Date:  2021-05-24

9.  Is the Scale for Measuring Motivational Interviewing Skills a valid and reliable instrument for measuring the primary care professionals motivational skills?: EVEM study protocol.

Authors:  Luis Á Pérula; Manuel Campiñez; Josep M Bosch; Nieves Barragán Brun; Juan C Arboniés; Julia Bóveda Fontán; Remedios Martín Alvarez; Jose A Prados; Enrique Martín-Rioboó; Josep Massons; Margarita Criado; José Á Fernández; Juan M Parras; Roger Ruiz-Moral; Jesús M Novo
Journal:  BMC Fam Pract       Date:  2012-11-22       Impact factor: 2.497

Review 10.  Pathogenesis of coronary artery disease: focus on genetic risk factors and identification of genetic variants.

Authors:  Sergi Sayols-Baixeras; Carla Lluís-Ganella; Gavin Lucas; Roberto Elosua
Journal:  Appl Clin Genet       Date:  2014-01-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.